Latin America Cancer Cachexia Market Size & Outlook
Latin America cancer cachexia market highlights
- The Latin America cancer cachexia market generated a revenue of USD 157.5 million in 2024.
- The market is expected to grow at a CAGR of 4.2% from 2025 to 2033.
- In terms of segment, appetite stimulants was the largest revenue generating treatment in 2024.
- Appetite stimulants is the most lucrative treatment segment registering the fastest growth during the forecast period.
Latin America data book summary
| Market revenue in 2024 | USD 157.5 million |
| Market revenue in 2033 | USD 228.2 million |
| Growth rate | 4.2% (CAGR from 2025 to 2033) |
| Largest segment | Appetite stimulants |
| Fastest growing segment | Appetite stimulants |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Appetite stimulants |
Other key industry trends
- In terms of revenue, Latin America region accounted for 6.2% of the global cancer cachexia market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 865.9 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cancer Cachexia Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Fresenius Kabi AG | View profile | 10001+ | Bad Homburg, Hessen, Germany, Europe | https://www.fresenius-kabi.com |
| Sandoz Group AG ADR | View profile | - | - | - |
| Endo Pharmaceuticals | View profile | 1001-5000 | Ballsbridge, Dublin, Ireland, Europe | http://www.endo.com |
| Bristol-Myers Squibb Co | View profile | 34100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | https://www.bms.com |
| Nestle SA | View profile | 270000 | Avenue Nestle 55, Vevey, Switzerland, CH-1800 | https://www.nestle.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Baxter International Inc | View profile | 60000 | One Baxter Parkway, Deerfield, IL, United States, 60015 | https://www.baxter.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
Latin America cancer cachexia market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cancer cachexia market will help companies and investors design strategic landscapes.
Appetite stimulants was the largest segment with a revenue share of 104.19% in 2024. Horizon Databook has segmented the Latin America cancer cachexia market based on appetite stimulants covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Latin America cancer cachexia market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Latin America cancer cachexia market databook
-
Our clientele includes a mix of cancer cachexia market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America cancer cachexia market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America cancer cachexia market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
